Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Van Gestel

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Clinical and Translational Radiation Oncology|December 21, 2023
<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effectLucas Schoenauen, François-Xavier Stubbe, Dirk Van Gestel, et al.
Frontiers in Oncology|May 21, 2026
Dual-energy and perfusion CT for predicting response to chemo-radiotherapy in head and neck cancer: an exploratory studyBenjamin Van Honacker, Yolène Lefebvre, Marianne Paesmans, et al.
Cells|January 10, 2025
Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck CancerTycho de Bakker, Anouk Maes, Tatiana Dragan, et al.
Trials|September 29, 2023
Assessment of radio(chemo)therapy-related dysphagia in head and neck cancer patients based on cough-related acoustic features: a prospective phase II national clinical trial (ACCOUGH-P/A trial)Sofiana Mootassim-Billah, Gwen Van Nuffelen, Jean Schoentgen, et al.
Radiation Oncology (London, England)|September 18, 2015
Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal frontsGeert De Kerf, Dirk Van Gestel, Lobke Mommaerts, et al.
Cancer Treatment and Research Communications|December 28, 2020
Successful treatment of synchronous chemoresistant pulmonary metastasis from pleomorphic rhabdomyosarcoma with stereotaxic body radiation therapy: A case report and a review of the literatureSofian Benkhaled, Maïmouna Mané, Christiane Jungels, et al.
Frontiers in Oncology|May 22, 2020
Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of IntensityPetr Szturz, Carl Van Laer, Christian Simon, et al.
Oral Oncology|October 7, 2019
Clinical outcome and toxicity after simultaneous integrated boost IMRT in head and neck squamous cell cancer patientsTatiana Dragan, Sylvie Beauvois, Michel Moreau, et al.
Frontiers in Oncology|February 12, 2026
Long-term outcomes and patient profiles following intensity-modulated radio-chemotherapy for nasopharyngeal cancer in a nonendemic regionTatiana Dragan, Ibrahim Chiairi, Maurine Salmon, et al.
The Oncologist|May 25, 2007
Intensity-modulated radiation therapy for head and neck carcinomaVincent Grégoire, Wilfried De Neve, Avraham Eisbruch, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Clinical and Translational Radiation Oncology|December 21, 2023
<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effectLucas Schoenauen, François-Xavier Stubbe, Dirk Van Gestel, et al.
Frontiers in Oncology|May 21, 2026
Dual-energy and perfusion CT for predicting response to chemo-radiotherapy in head and neck cancer: an exploratory studyBenjamin Van Honacker, Yolène Lefebvre, Marianne Paesmans, et al.
Cells|January 10, 2025
Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck CancerTycho de Bakker, Anouk Maes, Tatiana Dragan, et al.
Trials|September 29, 2023
Assessment of radio(chemo)therapy-related dysphagia in head and neck cancer patients based on cough-related acoustic features: a prospective phase II national clinical trial (ACCOUGH-P/A trial)Sofiana Mootassim-Billah, Gwen Van Nuffelen, Jean Schoentgen, et al.
Radiation Oncology (London, England)|September 18, 2015
Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal frontsGeert De Kerf, Dirk Van Gestel, Lobke Mommaerts, et al.
Cancer Treatment and Research Communications|December 28, 2020
Successful treatment of synchronous chemoresistant pulmonary metastasis from pleomorphic rhabdomyosarcoma with stereotaxic body radiation therapy: A case report and a review of the literatureSofian Benkhaled, Maïmouna Mané, Christiane Jungels, et al.
Frontiers in Oncology|May 22, 2020
Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of IntensityPetr Szturz, Carl Van Laer, Christian Simon, et al.
Oral Oncology|October 7, 2019
Clinical outcome and toxicity after simultaneous integrated boost IMRT in head and neck squamous cell cancer patientsTatiana Dragan, Sylvie Beauvois, Michel Moreau, et al.
Frontiers in Oncology|February 12, 2026
Long-term outcomes and patient profiles following intensity-modulated radio-chemotherapy for nasopharyngeal cancer in a nonendemic regionTatiana Dragan, Ibrahim Chiairi, Maurine Salmon, et al.
The Oncologist|May 25, 2007
Intensity-modulated radiation therapy for head and neck carcinomaVincent Grégoire, Wilfried De Neve, Avraham Eisbruch, et al.
Pageof 8